BIORA THERAPEUTICS INC - COM NEW (BIOR)

CUSIP: 74319F305

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COM NEW
Total 13F shares
12,051,093
Share change
+150,035
Total reported value
$13,255,746
Put/Call ratio
43%
Price per share
$1.10
Number of holders
24
Value change
+$147,072
Number of buys
9
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 74319F305?
CUSIP 74319F305 identifies BIOR - BIORA THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIORA THERAPEUTICS INC - COM NEW (BIOR) as of Q1 2024

As of 31 Mar 2024, BIORA THERAPEUTICS INC - COM NEW (BIOR) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,051,093 shares. The largest 10 holders included Athyrium Capital Management, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock Inc., STATE STREET CORP, Schonfeld Strategic Advisors LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, LPL Financial LLC, and JANE STREET GROUP, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.